Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1991 Jul;65(7):3864-72.
doi: 10.1128/JVI.65.7.3864-3872.1991.

Overlapping retrovirus U5 sequence elements are required for efficient integration and initiation of reverse transcription

Affiliations

Overlapping retrovirus U5 sequence elements are required for efficient integration and initiation of reverse transcription

D Cobrinik et al. J Virol. 1991 Jul.

Abstract

A secondary structure in the 5' noncoding region of avian retrovirus RNA, called the U5-leader stem, was shown previously to have a role in initiation of reverse transcription (D. Cobrinik, L. Soskey, and J. Leis, J. Virol. 62:3622-3630, 1988). We now show that an additional RNA secondary structure near the U5 terminus, called the U5-IR stem, is also important for reverse transcription. Mutations that disrupt the U5-IR stem cause a replication defect associated with both a decrease in synthesis of viral DNA in infected cells and a decrease in initiation of reverse transcription in melittin-permeabilized virions. Structure-compensating base substitutions in the U5-IR restore reverse transcription efficiency. In viral DNA, U5-IR sequences are included in the U5 terminal region that functions as a viral integration donor site. When base substitutions are introduced into these sequences, a reduced efficiency of integration in vitro and in vivo is observed. These observations indicate that U5-IR sequences have a structural role in reverse transcription of viral RNA and a sequence-specific role in the integration of viral DNA.

PubMed Disclaimer

References

    1. Cell. 1990 Oct 5;63(1):87-95 - PubMed
    1. J Biol Chem. 1979 Mar 25;254(6):1866-74 - PubMed
    1. J Virol. 1987 Oct;61(10):3004-12 - PubMed
    1. Methods Enzymol. 1987;155:335-50 - PubMed
    1. J Virol. 1989 Dec;63(12):5319-27 - PubMed

Publication types

LinkOut - more resources